pharmaphorum

MARCH 19, 2021

The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is very real, says Lifebit CEO, Dr Maria Chatzou Dunford. . on Big data: astronomical or genomical? ,

Bioinformatics 57

Bioinformatics Drugs Genome Genomics 57

pharmaphorum

MAY 23, 2022

The device will be worn by 2,000 people for a year, harvesting data on sleep status, heart rate, and activity levels, according to the study partners, which also include digital health and telemedicine firm MICIN and Tohoku University. ” The post Takeda, Daiichi-backed wearable study planned in Japan appeared first on.

Big Data 89

Big Data Genome Genomics Development 89

Drug Discovery World

SEPTEMBER 5, 2022

Throughout the continuum of drug development, from target discovery to patient selection, machine learning approaches are being adopted to reliably mine vast amounts of data and make predictions with higher accuracy Anita Ramanathan discusses how machine learning is currently used across different stages of cancer research. .

Development 52

Development Drugs Protein Genome 52

pharmaphorum

DECEMBER 8, 2022

The advent of biologic therapies in the 1970s along with the decoding of the human genome in 2003 heralded an explosion in pharmaceutical innovation. This has led to an increase in products coming to market with single‑arm Phase 3 data and surrogate endpoints or Phase 2b data, with planned confirmatory data to be released in the future.

Big Data 70

Big Data Gene Therapy Medicine Marketing 70

pharmaphorum

FEBRUARY 17, 2022

Identified as the “VB variant,” the virus has proved to be highly virulent and to speed up the progression of a patient developing AIDS faster. Led by researchers from the University of Oxford ‘s Big Data Institute, the study underscores the significance of analysing viruses continually over time.

Genome 92

Genome Genomics Genetics Genotype 92

XTalks

APRIL 5, 2021

The Human Genome Project could not have succeeded without the use of bioinformatics. Since the conclusion of the project in 2003, bioinformatics tools have been used to identify genes and elucidate their function with the aim of developing gene-based strategies for disease prevention, diagnosis and treatment.

Bioinformatics 59

Bioinformatics Engineer Scientist Genome 59

Drug Discovery World

FEBRUARY 6, 2024

From finding potential active substances and identifying novel targets, to simulating how drugs will function in the human body and optimising laboratory workflows, digital technologies are having a significant impact on drug discovery and development. The company’s platform evaluated more than 11.4

Marketing 69

Marketing Medicine Genome Genomics 69

Drug Discovery World

DECEMBER 27, 2023

Developing. Ng is working on critical challenges in clinical trials, specifically in planning and recruitment, and has been building innovative solutions designed to benefit patients and researchers – with a focus on efficiency, transparency and diversity in clinical development. DDW Highlights Innovative. Listen here. Listen here.

Clinical Trials 69

Clinical Trials Clinical Trials Drugs Development 69

pharmaphorum

APRIL 8, 2022

Dennis Kadioglu is the deputy head of both the Medical Informatics Group (MIG) and the Data Integration Center (DIC) at the University Hospital Frankfurt in Frankfurt am Main. In 2021, she co-founded OHDSI Germany, which is as a national node of the Observational Health Data Sciences and Informatics (OHDSI) Europe. .

Genome 56

Genome Genomics Research Big Data 56

pharmaphorum

JULY 4, 2022

And this is where modern technologies and data-driven medical informatics can really bridge the gaps in rare disease research,” said Dr Joanne Hackett, head of Genomic and Precision Medicine at IQVIA, during a recent pharmaphorum webinar. Data privacy and protection, patient voice.

Genome 101

Genome Genomics Research Medicine 101

Drug Discovery World

AUGUST 9, 2023

Another area of research which is really exciting for the whole industry is genomics and genetically targeted medicines. We are beginning to see the impact of big data and AI, enabling us to move a bit faster through the development process, and also to be more targeted in our R&D. That’s key for us.

Drugs 52

Drugs Antibody Big Data Medicine 52

Drug Discovery World

FEBRUARY 9, 2023

At the same time, we are developing a better understanding of disease pathology, leading to a more complicated picture of how diseases manifest. The first is that in-roads made in decoding the complexity of human disease will make drug discovery more difficult and costly, limiting the potential to develop new life-saving therapies.

Drugs 52

Drugs Development Big Data Scientist 52

pharmaphorum

MARCH 16, 2021

The use of real-world evidence is proving beneficial for pharma and medical devices companies across the lifecycle of development from R&D to re-purposing. Savana is unique as an EHR reuse provider and we have a community of doctors using this system in 14 countries in five languages.”. About Savana.

Doctors 107

Doctors Doctor Life Science Clinical Research 107

The Pharma Data

JANUARY 17, 2021

There has never been a time when rapid, low burden access to patient-level data, at scale, was more urgent. rows of data. Syntegra has also engaged with the Federal Drug Administration (FDA) to evaluate the role of synthetic data in regulatory decisions, for COVID-19 and beyond.

Life Science 52

Life Science Engineer Big Data Scientist 52

Drug Discovery World

NOVEMBER 18, 2022

It states that whilst some antibiotic prescribing can be “appropriate when risks for related bacterial or fungal infections are unknown,” this level of high prescribing can “put patients at risk for side effects and create a pathway for resistance to develop and spread.” . Still, there are positive developments occurring within the sector.

Bacteria 52

Bacteria Drugs Development Research 52

Delveinsight

FEBRUARY 17, 2021

Almost all the aspects of the healthcare sector, such as service delivery, communications, operation, medical equipment, and drug development, have grown remarkably and improved the overall health outcome. Improvement in the diagnostics, management of chronic conditions, drug and device development, are some of the key applications of AI.

Doctors 52

Doctors Doctor Big Data Development 52

The Pharma Data

JANUARY 4, 2021

Kiromic’s deep understanding of the tumor micro environment (TME) and the tumors’ escape and masking mechanisms led to development of a promising platform for chimeric antigen receptor therapy (CAR-T). PD-1 has always been a challenge for CAR-T development. “We believe Prof. About PD-1 Check-point inhibition.

In-Vivo 40

In-Vivo Development Big Data Immune Response 40

pharmaphorum

SEPTEMBER 18, 2020

The profits from these products funded the development of new drugs, such as gastroesophageal treatment Losec and cardiovascular treatment Aptin. “AstraZeneca will have a strong base for considerable expansion, especially in research and development and geographical presence. Zeneca Group plc. MedImmune acquisition.

Pharma Companies 113

Pharma Companies Sales Vaccination Vaccine 113

Drug Discovery World

SEPTEMBER 6, 2022

DDW Editor Reece Armstrong looks at the cell and gene therapy landscape, examining the challenges facing developers and the trends we can expect to see throughout the year. . Thompson says that the development of Covid-19 vaccines, which used mRNA technology, resulted in wider acceptance for cell and gene therapies. . “On

Gene Therapy 52

Gene Therapy Gene Manufacturing Medicine 52

Drug Discovery World

MAY 4, 2023

The potential of drug targets Over the next 50 years, new targets emerged and drugs were developed against them. The computational chemistry algorithms and force fields had developed in tandem with hardware, processors, parallel processing and supercomputers. Big data handling and machine learning made progress by leaps.

Medicine 52

Medicine Protein Drugs Bioassay 52